These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1378 related items for PubMed ID: 8178898

  • 1. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA, Stanczyk FZ.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [Abstract] [Full Text] [Related]

  • 2. [Information on advances in sciences and technology. Advances in contraceptive technology].
    Andrade AT.
    Bol Cent Biol Reprod; 1993 May; 12(1):51-2. PubMed ID: 12345521
    [Abstract] [Full Text] [Related]

  • 3. Long-acting hormonal contraceptives for women.
    Garza-Flores J, Hall PE, Perez-Palacios G.
    J Steroid Biochem Mol Biol; 1991 May; 40(4-6):697-704. PubMed ID: 1958567
    [Abstract] [Full Text] [Related]

  • 4. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A, Hahn DW, McGuire JL.
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [Abstract] [Full Text] [Related]

  • 5. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Oct; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 7. Menstrual impact of contraception.
    Stubblefield PG.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [Abstract] [Full Text] [Related]

  • 8. [Hormonal contraception].
    Van Cauwenberge JR.
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [Abstract] [Full Text] [Related]

  • 9. Vaginal rings for contraception: endocrine parameters.
    Olsson SE.
    Adv Contracept Deliv Syst; 1992 May; 8(1-2):71-3. PubMed ID: 12285565
    [Abstract] [Full Text] [Related]

  • 10. Prescription contraceptives: countering the risks.
    Ruggiero RJ.
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [Abstract] [Full Text] [Related]

  • 11. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B.
    Ann Pharmacother; 1995 Sep; 29(7-8):736-42. PubMed ID: 8520092
    [Abstract] [Full Text] [Related]

  • 12. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH.
    Ann N Y Acad Sci; 1988 Sep; 538():280-6. PubMed ID: 3056190
    [Abstract] [Full Text] [Related]

  • 13. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988 Sep; 9(3):1-3, 7. PubMed ID: 12315656
    [Abstract] [Full Text] [Related]

  • 14. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 15. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G, Kohlmeier L, Brenner H.
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [Abstract] [Full Text] [Related]

  • 16. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 17. [Preclinical research and development of norethisterone].
    Mcguire JL, Hahn DW, Philipps A.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [Abstract] [Full Text] [Related]

  • 18. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 19. Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.
    Back DJ, Houlgrave R, Tjia JF, Ward S, Orme ML.
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):219-25. PubMed ID: 2004043
    [Abstract] [Full Text] [Related]

  • 20. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.